Last updated: January 14, 2019
Sponsor: Yonsei University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Stomach Cancer
Digestive System Neoplasms
Gastric Cancer
Treatment
N/AClinical Study ID
NCT03430440
4-2016-1152
Ages 20-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
elective open gastrectomy due to stomach cancer
ASA classification Ⅰ-Ⅲ
Exclusion
Exclusion Criteria:
hematologic clotting defect
sepsis
distance metastasis
PCA drug (fentanyl, Ropivacaine) allergy
Patients who can not read the consent form or are not fluent in Korean (illiterate,foreigner)
pregnant, lactating women
Study Design
Total Participants: 76
Study Start date:
March 01, 2017
Estimated Completion Date:
November 11, 2020
Connect with a study center
Severance Hospital
Seoul, 03722
Korea, Republic ofActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.